{
    "2020-11-05": [
        [
            {
                "time": "2018-11-05",
                "original_text": "Incyte Earnings Miss Expectations; Tightens Outlook For Top Product",
                "features": {
                    "keywords": [
                        "Earnings Miss",
                        "Expectations",
                        "Tightens Outlook",
                        "Top Product"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-11-06",
                "original_text": "Incyte (INCY) Q3 Earnings & Sales Miss, Jakafi Demand Strong",
                "features": {
                    "keywords": [
                        "Q3 Earnings Miss",
                        "Sales Miss",
                        "Jakafi Demand Strong"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-11-07",
                "original_text": "Ionis (IONS) Misses Estimates for Q3 Earnings and Sales",
                "features": {
                    "keywords": [
                        "Misses Estimates",
                        "Q3 Earnings",
                        "Sales"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-11-08",
                "original_text": "Novartis CosentyxÂ® shows early synovitis reduction in patients with psoriatic arthritis in first-of-its-kind study",
                "features": {
                    "keywords": [
                        "Cosentyx",
                        "early synovitis reduction",
                        "psoriatic arthritis",
                        "first-of-its-kind study"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}